ROLE OF MEMORY T CELL DYNAMICS IN SIV INFECTION
ROLE OF MEMORY T CELL DYNAMICS IN SIV INFECTION
批准号:
8357743
负责人:
Louis J. Picker
金额:
$19.49万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30
关键词:
AffectB-LymphocytesCCR5 geneCD4 Positive T LymphocytesCD8B1 geneCellsChronicComplexDataDiseaseFailureFundingGrantHomeostasisImmuneImmunologic Deficiency SyndromesInfectionInterleukin-15Interleukin-7LinkMacaca mulattaMaintenanceMediatingMemoryMonkeysNational Center for Research ResourcesNatural regenerationPathogenesisPatternPopulationPrimatesPrincipal InvestigatorRelative (related person)ResearchResearch InfrastructureResourcesRoleSIVSiteSourceT memory cellT-Cell ProliferationT-LymphocyteThymus GlandUnited States National Institutes of HealthViralWorkcostimmune activationmemory CD4 T lymphocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Our work has provided compelling evidence that the onset of immune deficiency in pathogenic SIVmac239 infection of rhesus macaques (RM) is intimately linked with patterns of CD4+ memory T cell dynamics, and reflects a complex interplay of direct viral cytopathogenicity, and the indirect effects of persistent immune activation on CD4+ memory T cell proliferation, differentiation and survival. Our data have strongly implicated a decline in effector site, CD4+ effector memory (TEM) populations below a crucial threshold as a major proximate mechanism of overt immunodeficiency, but significantly, have also demonstrated that in CCR5-tropic SIV infection, even massive viral-mediated destruction of CD4+ TEM is rarely, if ever, sufficient for functional failure of this population. Instead, our data indicate that this failure is determined in large part by the ability of CD4+ central memory T cells (TCM) to produce new TEM, which in turn depends on the maintenance of the CD4+ TCM population itself. In chronic SIV infection, we found that a slow decline of the number and often, proliferative activity of CD4+ TCM underlies CD4+ TEM population failure, and "sets the clock" for the onset of overt disease. Recent work has focused on the mechanisms responsible for CD4+ TCM homeostatic failure, in particular the role of IL-7 and IL-15 in maintaining CD4+ TCM homeostasis and the relative contribution of recruitment of new TCM from the na¿ve compartment vs. regeneration of pre-existent TCM in the maintenance of the CD4+ TCM compartment during progressive SIV infection. By mAb-mediated depletion of CD4+ T cell in thymectomized monkeys, we have created "CD4 naiveless" RM after memory cells regenerate in the absence of a thymus. Importantly, the lack of a na¿ve CD4+ T cell compartment has little measureable effect on the maintenance of CD4+ memory T cells after SIV infection, suggesting that maintenance of this population depends predominantly on the regeneration of pre-existent memory cells as opposed to na¿ve cell recruitment. Other work in this project has looked at B cell dynamics in SIV infection and mechanisms by which CD8+ T cells affect SIV replications and pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Systemic analysis of the origin and tissue effects of the 68-1 RhCMV/SIV vaccine efficacy-predictive whole blood transcriptomic signature
-
批准号:10723639
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2023
-
负责人:Louis J. Picker
-
依托单位:
Admin Core
-
批准号:10709003
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
-
批准号:10619297
-
项目类别:
-
资助金额:$498.32万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
-
批准号:10709020
-
项目类别:
-
资助金额:$47.15万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Admin Core
-
批准号:10619298
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
-
批准号:10709002
-
项目类别:
-
资助金额:$503.93万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
-
批准号:10619304
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
-
批准号:9883700
-
项目类别:
-
资助金额:$232.2万
-
财政年份:2017
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8227957
-
项目类别:
-
资助金额:$81.28万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8416334
-
项目类别:
-
资助金额:$75.91万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8681307
-
项目类别:
-
资助金额:$337.74万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8880099
-
项目类别:
-
资助金额:$334.24万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
ASSESSMENT OF PD-I BLOCKADE AS A NEW IMMUNOTHERAPEUTIC APPROACH TO AIDS
-
批准号:8357789
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8140904
-
项目类别:
-
资助金额:$85.6万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
IMMUNE CORRELATES OF PROTECTION AGAINST SIV INFECTION
-
批准号:8357770
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8495905
-
项目类别:
-
资助金额:$338.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
HARNESSING INNATE IMMUNITY TO ENHANCE T-CELL INDUCING HIV VACCINES
-
批准号:8357757
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
REJUVENATION OF THE T-CELL COMPARTMENT IN AGING PRIMATES
-
批准号:8357808
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
CMV VECTOR DESIGN AND DEVELOPMENT
-
批准号:8357756
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8608474
-
项目类别:
-
资助金额:$83.12万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
海外基金